NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
11/26/2024
Back to search
Official data from USPTO
BIOSPRING
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BIOSPRING
ST13
US500000097839291Class
1, 5, 40, 42, 44
Filing
97839291
Registration
7345913
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
11/26/2024
Trademark type
Word
Nice classes
1, 5, 40, 42, 44
Filing date
03/14/2023
Registration date
04/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/02/2024
Last transaction
10/23/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/30/2017
First use in commerce
04/30/2017
Drawing code
4
Owner type
16
Owner location
Franfurt, DE
Examiner
PARK, JENNY K
Law office
L40
Current location
Historical data usage
Holders and representatives
Holders
B. M. (pessoa física)
Representatives
Julie A. Katz JULIE A. KATZ
Technical classification
Nice Classes
Class 1Class 5Class 40Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
oligonucleotides for use in the manufacture of pharmaceuticals; oligopeptides for industrial use; peptide substrates for scientific use; peptides for use in industry and science; peptides for use in research and the manufacture of reagentsdiagnostic reagents for science and research use; pharmaceutical intermediates for use in the further manufacture of pharmaceuticals; phosphoproteins; proteins for use in industry and science; reagents for research purposes; reagents for scientific use; nucleic acid for diagnostic research; nucleic acid for diagnostic manufacturing
Class 5
nucleic acid reagentsagentspreparations and substances for medical purposes; nucleic acid sequences for medical and veterinary use; oligonucleotides for diagnostic purposes; oligonucleotides for medical diagnostic purposes; oligonucleotides for medical use; oligonucleotides for pharmaceutical purposes; pharmaceutical preparations against genetic diseases; pharmaceutical preparations against metabolic diseases; pharmaceutical preparations against neurological diseases; pharmaceutical preparations for the treatment of cardiovascular diseasescentral and peripheral nervous system diseasesrespiratory diseasescancerallergiesgynecological diseasesrheumatic diseasesurological diseasesgastroenterological diseasesinfectious diseaseseye diseasedermatological diseasesautoimmune diseasesblood diseasesgenital diseasesendocrine diseasesintestinal diseasesinternal medicine diseases; pharmaceutical preparations for wound healing; reagents for medical purposes; reagents for medical use; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing; tumor suppressing agents
Class 40
biochemical contract manufacturing services; chemical synthesis servicescustom synthesis of chemicals for others; custom manufacture of biopharmaceuticals; custom manufacture of pharmaceuticals; custom manufacturing of oligonucleotides; custom modification of antibody; custom modification of protein; development servicesdesign and development of manufacturing processes for others in the field of oligonucleotides; manufacturingcontract manufacturing in the field of oligonucleotides; processing of biopharmaceutical materials for others; processing of chemical reagents; processing of chemicals; processing of medicinal materials; processing of oligonucleotides; processing of peptides; processing of proteins; technical and scientific servicesproviding technical information in the field of pharmaceutical manufacturing
Class 42
scientific analysis services for the identification and physical characterization of chemical molecules; scientific and technical servicesscientific analysis of industrial installations; scientific and technological servicesapplied scientific research and development servicesconception of development or commercial batches for third parties in the fields of pharmaceuticals and chemicals; scientific and technological servicesconsulting and assistance in the research and development of chemicals and pharmaceuticalsincluding experimental and production processes and installations; scientific and technological servicesconsulting and assistance in the research and development of pharmaceuticals; scientific development services in the field of biochemistry; scientific laboratory services; scientific research and development services for chemicals for the products of third partiesthe scientific and technical development of synthetic processes in the field of chemistry and biochemistry; scientific research and development services in the field of pharmaceuticals; scientific research and scientific and technical development in the field of pharmaceuticalchemicalagrochemical and industrial processes; scientific research servicesnucleic acid analysis; scientific research servicesoligonucleotide analysis; scientific servicesscientific analysis allowing the identification and physical characterization of chemical molecules; scientific servicesscientific research and industrial analysis in the field of pharmaceuticalschemicalsagrochemical and industrial processes; scientific study and research in the area of industrial quality; development of methods of analysis for chemical and pharmaceutical products and bio-organics; scientific study and research services in the field of industrial safety
Class 44
nucleic acid analysis for medical diagnostic and treatment purposes; oligonucleotide analysis for medical diagnostic and treatment purposes
Publications
History of USPTO decisions and trademark events.
26 publications found
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
10/24/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
10/23/2024
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
10/23/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
10/22/2024
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
09/17/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/10/2024
ES7R
TEAS SECTION 7 REQUEST RECEIVED
04/12/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/02/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/16/2024
PUBO
PUBLISHED FOR OPPOSITION
01/16/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/27/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/14/2023
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
12/14/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
12/13/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/13/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
12/13/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/13/2023
IUAA
USE AMENDMENT ACCEPTED
12/13/2023
DOCK
ASSIGNED TO EXAMINER
12/11/2023
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
08/25/2023
IUAF
USE AMENDMENT FILED
08/25/2023
EAAU
TEAS AMENDMENT OF USE RECEIVED
08/24/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/04/2023
NWAP
NEW APPLICATION ENTERED
03/17/2023
Continuous trademark protection
Get notified about every new filing that threatens BIOSPRING or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.